Your SlideShare is downloading. ×
Critical care market to 2019   growth from factor concentrates new indications and increasing demand for albumin in asia-pacific - Reports Corner
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Critical care market to 2019 growth from factor concentrates new indications and increasing demand for albumin in asia-pacific - Reports Corner

156

Published on

GBI Research, the leading business intelligence provider, has released its latest research, "Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for …

GBI Research, the leading business intelligence provider, has released its latest research, "Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific". The report provides in-depth analysis of the drivers and barriers that affect the global critical care market.

https://www.reportscorner.com/reports/20856/Critical-Care-Market-to-2019---Growth-from-Factor-Concentrates-New-Indications-and-Increasing-Demand-for-Albumin-in-Asia-Pacific/

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
156
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. RCReports CornerCritical Care Market to 2019 - Growth from Factor Concentrates NewIndications and Increasing Demand for Albumin in Asia-Pacific
  • 2. DescriptionDescriptionReports Cornerwww.reportscorner.comGBI Research, the leading business intelligence provider, hasreleased its latest research, "Critical Care Market to 2019 - Growthfrom Factor Concentrates New Indications and IncreasingDemand for Albumin in Asia-Pacific". The report provides in-depthanalysis of the drivers and barriers that affect the global criticalcare market.
  • 3. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comCritical Care Market to 2019 - Growth from Factor ConcentratesNew Indications and Increasing Demand for Albumin in Asia-PacificSummaryGBI Research, the leading business intelligence provider, hasreleased its latest research, "Critical Care Market to 2019 - Growthfrom Factor Concentrates New Indications and IncreasingDemand for Albumin in Asia-Pacific". The report provides in-depthanalysis of the drivers and barriers that affect the global criticalcare market. The report has been compiled using data andinformation sourced from proprietary databases, primary andsecondary research, and in-house analysis carried out by GBIResearchs team of industry experts.
  • 4. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comThe report analyzes the markets for factor XIII concentrates,fibrinogen concentrates, albumins, antithrombins andprothrombin complex concentrates in the US, the top fivecountries of Europe (the UK, Germany, France, Italy and Spain),and Japan. The report does also provide an overview on Asia-Pacific countries, including China, India and Australia.The report provides an overview of major marketed products incritical care market along with treatment usage patterns, averageannual cost of therapy and market forecast to 2019 for keygeographical markets, as well as for leading therapeuticsegments. The report also provides information on the Researchand Development (R&D) product pipeline and explores thecompetitive landscape, including the provision of profiles formajor players in the critical care market. Finally, the reportincludes analysis of Mergers and Acquisitions (M&A) activity inthe critical care market.
  • 5. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comGBI Researchs analysis indicates that the global critical caremarket is still an untapped market, with a small number of playersaccounting for a major proportion of the overall market. Themarket grew at a very slow growth rate between 2006 and 2012,possibly due to the lac of availability of many of the products incertain markets, especially in the US.GBI Research estimates that the overall critical care therapeuticsmarket was worth $2.3 billion in 2012, having grown in size at aCAGR of 11% from $1.2 billion in 2006. The market is expected togrow at a CAGR of 5% to reach $3.2 billion in 2019. The double-digit market growth registered between 2006 and 2012 can beattributed primarily to the increased demand for and cost ofalbumin, as well as the approval and launch of new products.
  • 6. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comThe growth of the overall critical care market during the forecastperiod is expected to be largely due to an increasing preference inthe market for factor concentrates such as Riastap, Corifact, rFXIII(which has been launched in the EU and is expected to belaunched in the US later this year), the expanded indication forAntithrombin (AT) III and factor concentrates, and rising demandfor albumin from countries in the Asia-Pacific region. Stagnantinnovations, a low prevalence rate and the consequent limitedavailability of patients are some of the factors impeding thegrowth of the critical care market.Scope- Data and analysis regarding the critical care market in leadinggeographical locations – the US, the UK, Germany, France, Italy,Spain, and Japan and Asia-Pacific countries, including India,China and Australia.
  • 7. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- Annualized market data for the critical care market, including theindividual markets for factor XIII concentrate, fibrinogenconcentrate, antithrombin, prothrombin complex concentrate andalbumin from 2006 to 2012, with forecasts provided up to 2019.- Market data on the geographical landscape and therapeuticlandscape, including market size, market share, cost of therapy,sales volume, and treatment usage patterns, such as diseasepopulation, diagnosis population and prescription population.- Key drivers and restraints that have had a major impact upon themarket.- An overview of the competitive landscape of the global criticalcare market, including benchmarking for leading companies.Some of the key companies studied in this report are CSL,Octapharma, Baxter, Grifols, and LFB.- Key M&A activities that took place in 2010 and 2011 in the criticalcare market.
  • 8. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comReasons to buy- Align company product portfolios to markets with high growthpotential.- Build effective strategies to launch pipeline products, byidentifying potential geographical markets.- Exploit in-licensing and out-licensing opportunities byidentifying products that might fill portfolio gaps.- Develop key strategic initiatives by studying the key strategies oftop competitors.- Devise a more tailored country strategy through theunderstanding of key drivers and barriers and market potential ofeach indication.- Develop market-entry and market expansion strategies byidentifying the geographic markets poised for strong growth.
  • 9. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- Reinforce R&D pipelines by identifying new target mechanismscapable of producing first-in-class molecules which are safer andmore efficacious
  • 10. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com1 Table of Contents1 Table of Contents 51.1 List of Tables 81.2 List of Figures 92 Introduction 103 Critical Care Market to 2019 – Global Overview 114 Critical Care Market to 2019 – Geographical Landscape 134.1 Introduction 134.2 The US – Critical Care Market 144.2.1 Revenue 144.3 Top Five European Countries – Critical Care Market 164.3.1 Revenue 164.4 Japan – Critical Care Market 184.4.1 Revenue 185 Critical Care Market to 2019 – Albumin Market 19
  • 11. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com5.1 Introduction 195.2 Marketed Albumin Products 215.2.1 Buminate 215.2.2 Zenalb 215.2.3 Human Albumin Biotest 215.2.4 AlbuRx 225.2.5 Albuminar 225.2.6 Albutein 225.2.7 Albuked 235.2.8 Vialebex 235.2.9 Albunorm 235.2.10 AlbuRAAS 235.3 Revenue 245.4 Cost of Therapy 265.5 China 27
  • 12. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com5.5.1 Introduction 275.5.2 Strict Regulatory Reforms Leading to Tighter Supply 275.5.3 Fragmented Market Dominated by Overseas Players 275.5.4 Price of Albumin Likely to Remain High 275.5.5 Conclusion 285.6 India 285.7 Australia 285.7.1 Introduction 285.7.2 Rising Albumin Demand 295.7.3 Australian Albumin Market 295.8 Market Drivers and Barriers 305.8.1 Market Drivers 305.8.2 Market Barriers 316 Critical Care Market to 2019 – Antithrombin Concentrate Market 326.1 Introduction 32
  • 13. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com6.1.1 Marketed Antithrombin Concentrate Products 336.1.2 Revenue 386.1.3 Geographical Segmentation 406.1.4 Cost of Treatment 426.1.5 Treatment Usage Pattern 436.2 Drivers and Restraints 456.2.1 Drivers 456.2.2 Restraints 467 Critical Care Market to 2019 – Fibrinogen Concentrate Market 477.1 Introduction 477.2 Marketed Fibrinogen Concentrates 487.2.1 Haemocomplettan/Riastap 487.2.2 Clottafact 487.2.3 Other Marketed Fibrinogen Concentrates 497.2.4 Revenue 49
  • 14. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com7.2.5 Geographical Segmentation 517.3 Market Segmentation 537.3.1 Cost of Treatment 557.4 Treatment Usage Pattern 567.5 Drivers and Barriers 597.5.1 Drivers 597.5.2 Barriers 608 Critical Care Market to 2019 – Prothrombin Complex Concentrate Market 618.1 Introduction 618.2 Marketed Products 638.2.1 Beriplex P/N 638.2.2 Confidex 638.2.3 Profilnine SD 638.2.4 Uman Complex DI 648.2.5 Kaskadil 64
  • 15. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com8.2.6 Octaplex 500 648.2.7 Cofact 648.2.8 Feiba VH 648.2.9 Bebulin VH 658.3 Revenue 658.3.1 Revenue Breakdown 678.4 Geographical Segmentation 688.5 Cost of Therapy 698.5.1 Treatment Usage Pattern 718.6 Drivers and Restraints 728.6.1 Drivers 728.6.2 Barriers 739 Critical Care Market to 2019 – Factor XIII Concentrate Market 749.1 Introduction 749.2 Marketed Products 75
  • 16. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com9.2.1 Fibrogammin / Corifact 759.3 Revenue 769.3.1 Geographical Segmentation 789.3.2 Cost of Treatment 819.3.3 Treatment Usage Pattern 839.4 Drivers and Restraints 859.4.1 Drivers 859.4.2 Restraint 8610 Critical Care Market to 2019 – Research and Development Product Pipeline 8710.1 Introduction 8710.1.1 rFXIII (NovoThirteen) 8911 Critical Care Market to 2019 – Competitive Landscape 9011.1 CSL Limited 9011.2 Baxter International Incorporated 9011.3 Grifols, SA 90
  • 17. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com11.4 Octapharma AG 9011.5 Kedrion SpA 9111.6 Biotest 9111.7 Laboratoire Français de Fractionnement et de Biotechnologies 9111.8 Bio Products Laboratory Limited 9111.9 Sanquin Blood Supply Foundation 9111.10 China Biologic Products, Incorporated 9211.11 Hualan Biological Engineering, Incorporated 9211.12 Shanghai RAAS Blood Products Company, Limited 9212 Critical Care Market to 2019 – Strategic Consolidation 9312.1 Grifols Acquisition of Talecris Biotherapeutics in June 2011 9312.2 LFB Biotechnologies Acquisition of GTC Biotherapeutics in December 2010 9312.3 ViroPharma Expands Licensing Agreement with Sanquin Blood Supply Foundation in January 20109413 Critical Care Market to 2019 – Appendix 9513.1 Market Definitions 95
  • 18. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com13.2 Abbreviations 9513.3 Bibliography 9613.4 Research Methodology 9813.4.1 Coverage 9813.4.2 Secondary Research 9813.4.3 Primary Research 9913.5 Therapeutic Landscape 9913.5.1 Market 10113.6 Geographical Landscape 10213.7 Pipeline Analysis 10213.8 Competitive Landscape 10213.8.1 Expert Panel Validation 10213.9 Contact Us 10213.10 Disclaimer 102
  • 19. For more informationFor more informationReports Cornerwww.reportscorner.comFor more information please visit our websitehttps://www.reportscorner.com/reports/20856/Critical-Care-Market-to-2019---Growth-from-Factor-Concentrates-New-Indications-and-Increasing-Demand-for-Albumin-in-Asia-Pacific/
  • 20. Reports CornerThank YouThank Youwww.reportscorner.comRCContact us: contact@reportscorner.com

×